The evaluation of proarrhythmic and hemodynamic liabilities for new compounds remains a major concern of preclinical safety assessment paradigms. Contrastingly, albeit functional liabilities can also translate to clinical morbidity and mortality, lesser preclinical efforts are focused on the evaluation of drug-induced changes in inotrope and lusitrope, particularly in the setting of concomitant hemodynamic/arrhythmic liabilities. This study aimed to establish the feasibility of an anesthetized guinea pig preparation to assess functional liabilities in the setting of simultaneous druginduced electrocardiographic/hemodynamic changes, by evaluating the effects of various compounds with known cardiovascular properties on direct and indirect indices of left ventricular function. In short, twenty nine male guinea pigs were instrumented to measure electrocardiograms, systemic arterial pressure, and left ventricular pressure-volume relationships. After baseline measurement, all animals were given intravenous infusions of vehicle and two escalating concentrations of either chromanol 293B (n = 8), milrinone (n = 6), metoprolol (n = 7), or nicorandil (n = 8) for 10 minutes each. In all cases, these compounds produced the expected changes. The slope of preload-recruitable stroke work (PRSW), a pressure-volume derived load independent index, was the most sensitive marker of drug-induced changes in inotropy. Among the indirect functional indices studied, only the "contractility index" (dP/dt max normalized by the pressure at its occurrence) and the static myocardial compliance (ratio of end diastolic volume and pressure) appeared to be adequate predictors of druginduced changes in inotropy/lusitropy. Overall, the data confirms that both electrophysiological and mechanical liabilities can be accurately assessed in an anesthetized guinea pig preparation.
The evaluation of proarrhythmic and hemodynamic liabilities for new compounds remains a major concern of preclinical safety assessment paradigms. Contrastingly, albeit functional liabilities can also translate to clinical morbidity and mortality, lesser preclinical efforts are focused on the evaluation of drug-induced changes in inotrope and lusitrope, particularly in the setting of concomitant hemodynamic/arrhythmic liabilities. This study aimed to establish the feasibility of an anesthetized guinea pig preparation to assess functional liabilities in the setting of simultaneous druginduced electrocardiographic/hemodynamic changes, by evaluating the effects of various compounds with known cardiovascular properties on direct and indirect indices of left ventricular function. In short, twenty nine male guinea pigs were instrumented to measure electrocardiograms, systemic arterial pressure, and left ventricular pressure-volume relationships. After baseline measurement, all animals were given intravenous infusions of vehicle and two escalating concentrations of either chromanol 293B (n = 8), milrinone (n = 6), metoprolol (n = 7), or nicorandil (n = 8) for 10 minutes each. In all cases, these compounds produced the expected changes. The slope of preload-recruitable stroke work (PRSW), a pressure-volume derived load independent index, was the most sensitive marker of drug-induced changes in inotropy. Among the indirect functional indices studied, only the "contractility index" (dP/dt max normalized by the pressure at its occurrence) and the static myocardial compliance (ratio of end diastolic volume and pressure) appeared to be adequate predictors of druginduced changes in inotropy/lusitropy. Overall, the data confirms that both electrophysiological and mechanical liabilities can be accurately assessed in an anesthetized guinea pig preparation.
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While pro-arrhythmic and hemodynamic liabilities of new compounds remains a major concern of preclinical safety evaluation (Pugsley et al., 2008; Sarazan et al., 2011) , many other vital cardiovascular functions/states (eg, myocardial inotrope/lusitrope, vascular resistances) are seldom interrogated under current risk assessment paradigms. However, if affected by drugs, changes in these "hidden" or "orphan" cardiovascular targets can translate to mortality and morbidity (Hamlin and del Rio, 2010) ; for instance, according to previous reports of clinical trials, many clinically available drugs are either cardio-toxic and/or change myocardial inotropy (Force and Kolaja, 2011) . That these drugs have reached the market and are still in use may be explained by the fact that all potentially important parameters are not interrogated. Another reason for errors in prediction is that safety pharmacology is conducted most often on normal surrogates for man, despite the fact that drugs are seldom given to normal persons but instead to persons with hypertension, heart failure, diabetes, and obesity (to mention but a few), conditions known predispose to drug toxicity.
Given the growing population of patients with underlying cardiovascular disease, the assessment of both on-and offtarget changes in myocardial function (inotropy and lusitropy) should be of primal importance. In practice, inotrope maybe determined or inferred from either invasive (ie, end systolic pressure-volume relationship, ESPVR; preload recruitable stroke work, PRSW; the maximum rate of rise of left ventricular pressure, dP/dt max ; the maximal velocity of contractile element at no load, V max ; the duration from the beginning of the Q wave on electrocardiograms to the onset of the aortic blood pressure pulse, QA interval; the maximal dP/dt divided by the pressure at this point, contractility index) or non-invasive methods (ie, Tei index; ratio of pre-ejection period over ejection time, PEP:ET; left ventricular fractional shortening, LVFS. However, the gold standard for the measurement of inotrope is the end-systolic pressure-volume relationship (Suga et al., 1973) . It is difficult toxicological sciences 137(2), 458-468 2014 doi:10.1093/toxsci/kft244 Advance Access publication November 4, 2013 Downloaded from https://academic.oup.com/toxsci/article-abstract/137/2/458/1674932 by guest on 07 February 2019 Assessment of CArdiAC funCtion And eCG in GP to obtain pressure-volume loops of good quality, and the calculations and interpretations are also challenging, but the results provide enormously important information about properties of cardiac function (eg, inotrope, lusitrope, energetics, stroke volume) more than any other methods or groups of methods.
Despite lacking a strong transient outward potassium (I to ) channel, guinea pigs are among the most useful animal models serving as surrogates for humans in Safety Pharmacological studies (Hamlin, 2007; McDermott et al., 2002) . The sensitivity and specificity of identifying changes of clinical significance interrogated on studies conducted on isolated guinea pig hearts were previously validated in our lab (Hamlin et al., 2003) and in others (Cheng et al., 2006; Guo et al., 2009) . Various investigators have also evaluated anesthetized guinea pig models for the assessment of drug effects on electrocardiograms, hemodynamics, and left ventricular pressure; however, none studied the effect of drugs on inotrope, lusitrope, or myocardial energetics simultaneously with assessment of electrocardiographic parameters (Fossa et al., 2007; Hauser et al., 2005; Sakaguchi et al., 2005; Takahara et al., 2005 Takahara et al., , 2006 . Recently, the baroinometry index (dP/dt max ) and QA interval (QAI) were studied in the anesthetized guinea pigs (Mooney et al., 2012) but those parameters, while rather easy to obtain, are load dependent (dP/dt max and QAI) and depend also on elastic properties of the aorta and electropressure latency (QAI), therefore they are not unique for being affected by inotrope.
This study was designed to test the hypothesis that assessment of inotrope, both by direct (relationships from pressurevolume loops) and indirect (pressure-derived indices) methods can be performed simultaneously to the assessment of electrocardiographic and hemodynamic liabilities in anesthetized, closed-chest, guinea pigs. As such, this study evaluated the effects of various reference compounds ranging from positive (milrinone) to negative inotropes (metoprolol) and from QT lengthening (chromanol 293B) to QT shortening (nicorandil) compounds on ventricular function (inotropic and lusitropic properties), in the pentobarbital anesthetized guinea pigs.
MATeRIAlS And MeThOdS
Animals. All animals used in this study were cared for and used in accordance with the requirements outline by the Faculty of Veterinary Science, Chulalongkorn University and QTest Labs, LLC. The care and use of all animals were in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) . Twenty nine male guinea pigs, weighing between 425 and 452 g were used. The environment was controlled at 24 ± 1°C, relative humidity between 50% and 60%, and with a 12:12-h lightdark cycle. All guinea pigs were fed a standard laboratory diet and had filtered tap water ad libitum. Surgical Preparation and Instrumentation. All guinea pigs were given sodium pentobarbital (60-80 mg/kg, IP) to achieve a level of surgical anesthesia. Following induction, the animals were endotracheally intubated (via a tracheotomy), and mechanically ventilated (~70-75 breaths/min, ~2.5 ml tidal volume with a 95% O 2 and 5% CO 2 mixture) via an adjustable small animal ventilator (Harvard Apparatus, model 680). In-dwelling catheters were placed in the left and right jugular veins for the infusion of anesthetic agents (left) and vehicle/test articles (right). Once a proper anesthetic level was established and verified (eg, non-responsive to toe pinch), the animals were paralyzed with atracurium (0.03 ml, IV bolus) and anticoagulated (heparin 30 units, IV bolus). A surgical plane of anesthesia was maintained via the continuous infusion (0.3 ml/h, IV) of a solution containing 0.5 ml sodium pentobarbital, 0.1 ml atracurium besylate, and 3.5 ml normal saline. It is important to note that muscular paralysis is necessary for this model to arrest spontaneous ventilation in order to obtain stable pressure-volume loops during venous occlusion. The anticoagulation was used for the entire experiment to prevent blood clotting which may resulted in thromboembolism. Body temperature was continuously monitored throughout the duration of the experiment via a rectal probe, and was maintained within physiological range via a temperature-controlled (closed-loop) small animal surgical table/control unit.
Subsequently, transthoracic needle electrodes forming a single-lead ECG (lead II) were placed at right 4th intercostal space (negative lead) and left 6th intercostal space (positive lead). The right carotid artery was isolated, dissected free from the surrounding tissue, and cannulated with a 1.2 Fr high-fidelity pressure-volume, admittance catheter (Model FTH-1212B-4518, Scisense, Ontario, Canada). In order to simultaneously determine left-ventricular pressure and volume, this catheter was advanced retrogradely across the aortic valve into the left ventricle (LV). The abdominal cavity was opened via a midline incision, and a custom made vessel-occluder was securely placed on the abdominal vena cava to obstruct venous return and generate curves (Cyon-Frank-Starling) of heterometric autoregulation. In order to record arterial pressures, a 2 Fr highfidelity micromanometer (Model SPR-407, Millar Instrument) catheter was inserted into the left carotid artery.
Experimental Protocols. After instrumentation and hemodynamic stabilization, baseline data were collected. Subsequently, a vehicle (0.9% normal saline or 0.1% DMSO) was infused at a rate of 1.0 ml/kg/10 min. After the end of vehicle infusion, escalating concentrations of the reference test article(s) were given to identify the precision with which inotrope and lusitrope could be determined. The ino-dilator, milrinone (0.3 and 0.9 mg/kg/10 min) was administered to produce positive inotrope with a reduction in systemic arterial pressure. The β 1 -adrenoceptor antagonist, metoprolol (0.3 and 0.7 mg/kg/10 min) was administered to produce negative inotropism (Schliep and Harting, 1984) . Chromanol 293B (1 and 3 mg/kg/10 min), a selective blocker of the slow component (I Ks ) of delayed rectifier potassium channel, was administered to show a lengthening of QT interval and associated with torsades de pointes (Yang et al., 2004) . Nicorandil (0.3 and 2.7 mg/kg/10 min), an I K. ATP channel opener, was chosen because it is known to shorten the QT interval and is associated with ventricular fibrillation (Nakahashi et al., 2005) . All measurements were taken at the end of infusions of either vehicle or test compounds. Following the second dose and subsequent data collection, each animal was given an intravenous bolus of metoprolol (0.5 mg/kg) and a measurement was taken 5 min after dosing to validate that each preparation responded with negative inotrope to a known negative inotrope. At the end of experiment, all animals were euthanized with intravenous pentobarbital sodium (100 mg/kg).
Previous study with vehicle infusion alone was performed to establish that there was no significant difference in PRSW from the beginning (36.1 ± 1.1 mmHg) to the end (34.7 ± 0.5 mmHg) of 3-h experiment (Ueyama et al., 2012) .
Measurement of Left Ventricular Mechanics (Pressure-Volume Loops, PVL).
Once a steady hemodynamic state was reached at a given time-point after dosing, left-ventricular pre-load was acutely reduced by means of brief (~8-10 beats) caudal vena caval occlusions in order to generate a family of pressure-volume curves/loops; approximately three occlusions were performed at each time-point, allowing for hemodynamic recovery between occlusions. The resulting left-ventricular pressure and volume data were analyzed both onand off-line in order to generate relationships representing the contractile and energetic state of the myocardium to each dose of test article.
Drugs.
A solution of 0.9% NaCl or 0.1% DMSO was used for vehicle infusion. Milrinone and nicorandil were purchased from Sigma-Aldrich Kijtawornrat Et al.
and were dissolved in 0.9% NaCl. Chromanol 293B was purchased from Sigma-Aldrich and was dissolved in 0.1% DMSO. Metoprolol tartrate (Novaplus, 1 mg/ml) was purchased as an injectable solution from Bedford (Ohio).
Data Acquisition and Analysis. Throughout the experiments, analog signals were digitally sampled (1000 Hz) and recorded continuously with a data acquisition system (IOX; EMKA Technologies). The following ECGderived indices/parameters were measured offline with the aid of patternrecognition software (ECG Auto; EMKA Technologies): HR, RR, PQ, QRS, QT interval, QA interval, and Fridericia's rate-corrected QT (QTcF). Mean systemic blood pressure (MBP) was measured. Meanwhile, left-ventricular mechanical and/or geometrical indices were obtained from the pressure waveform [contractility index (CI = the maximal dP/dt divided by the pressure at this point); end diastolic volume, EDV; end diastolic pressure, EDP; the maximum rate of rise of the left ventricular pressure, dP/dt max ; the maximum rate of fall of the left ventricular pressure, dP/dt min ; time-constant of relaxation, tau, and isovolumetric left ventricular relaxation, RT]. In addition, the slope of the relations between stroke work (SW) and end-diastolic volume (linear), also called preload recruitable stroke work (PRSW) was derived by graphing left-ventricular pressure versus left ventricular volume (PV) loops generated during brief periods of venous occlusion leading to preload reduction.
Statistical Analysis. Data are presented as mean ± standard error of mean. Percent changes from baseline were assessed and the effects of each concentration for individual compounds were compared to vehicles using one-way ANOVA followed by Dunnet's test. Correlations were calculated using a commercial software package. Differences were considered significant for P-values less than 0.05.
ReSulTS
Electrocardiograms, aortic blood pressures, and left ventricular pressures of good quality for interpretation were obtained from all guinea pigs. Slopes of ESPVR and PRSW were obtained from PV loops inscribed during brief periods of heterometric autoregulation at baseline and after high doses of exposure to test articles (Figs. 1 and 2 A-D).
Effects of vehicles on electrocardiograms, hemodynamics, and LV functions:
Intravenous administrations of both 0.9% normal saline and 0.1% DMSO did not significantly affect any cardiovascular parameters (Figs. 3-6 ). ECG parameters did not shown any changes in intervals and rhythm. No extrasystole was observed during vehicle infusion. The mean percentage change of ECG parameters varied between −1.7% and 2.9%, which represented a normal physiological variation. Changes of hemodynamics and LV functions were within ±6.1%.
Effects of Test Compounds on Electrocardiograms
Effects of selected compounds (chromanol 293B, n = 8; milrinone, n = 6; metoprolol, n = 7, and nicorandil, n = 8) on RR, PQ, QT, and QTcF intervals in anesthetized guinea pigs after intravenous administrations of different concentrations are shown (Figs. 3A-D) . Chromanol 293B caused dose-dependent increases in RR interval (decrease in heart rate) and PQ interval (negative dromotrope) although they were not significant (Figs. 3A and 3B ). Intravenous administration of chromanol 293B produced a dose-dependent prolongation of QT interval up to a maximum of 11.6% ± 2.1% (Fig. 3C) . After correction of QT interval for change in heart rate by Fridericia's formula, a lengthening of QTcF interval was still observed for both low (6.8% ± 1.1%) and high (9.9% ± 1.4%) doses (Fig. 3D ). Extrasystoles were rarely observed during chromanol 293B infusion.
Metoprolol caused a rapid and significant prolongation of RR interval (low dose: 18.7% ± 4.3% and high dose: 22.4% ± 3.6%), PQ interval (low dose: 12.3% ± 2.3% and high dose: 20.3% ± 1.9%), and QT interval (low dose: 13.1% ± 3.3% and high dose: 15.7% ± 2.7%). After correction of QT interval for change in heart rate by Fridericia's formula, QTcF interval was still significantly lengthened for both low and high doses (7.3% ± 1.7% and 8.6% ± 2.2%, respectively). No extrasystole was observed during metoprolol infusion.
When comparing baseline-adjusted percent change from vehicle, milrinone had no effect on PQ interval but produced dose-dependent and significant shortening of RR interval (low dose: −11.2% ± 3.8% and high dose: −23.9% ± 4.5%), QT interval (low dose: −19.2% ± 4.8% and high dose: −25.1% ± 4.8%), and QTcF intervals (low dose: −14.9% ± 3.5% and high dose: −16.4% ± 2.7%). Extrasystoles were rarely observed during milrinone infusion.
Intravenous administration of nicorandil (0.3 and 2.7 mg/ kg/10 min) had no effect on either RR interval or PQ interval. Nicorandil tended to shorten QT and QTcF intervals with the low dose, and became significantly shorter with the high dose (QT: −12.5% ± 3.0% and QTcF: −9.5% ± 2.3%, respectively). No extrasystole was observed during nicorandil infusion. 
Effects of Test Compounds on Mean Systemic Arterial Blood Pressure (MBP)
Infusion of chromanol 293B either low or high doses did not alter MBP (Fig. 4) . Metoprolol and milrinone caused significantly dose-dependent decreases in MBP at low and high doses (−17.9% ± 5.8% and −35.1% ± 13.6% for metoprolol; −55.3% ± 8.5% and −102.4% ± 9.2% for milrinone, respectively). Nicorandil decreased MBP significantly only at the high dose (−81.9% ± 11.1%). 
Effects of Test Compounds on Left Ventricular Inotrope
Infusion of chromanol 293B did not alter PRSW, contractility index, dP/dt max , or QA interval at either low or high doses. Metoprolol (low and high doses) increased QA interval significantly and reduced PRSW, contractility index, and dP/dt max significantly (Figs. 5A-D) . Metoprolol also produced significant decreases in PRSW, contractility index, and dP/dt max after these indices of contractility had been increased in response to positive inotropes.
Milrinone caused significant increases in PRSW for low and high doses; however, it tended to decrease dP/dt max at both doses. Milrinone tended to increase the contractility index at the low dose, but increased the contractility index significantly at the high dose. Nicorandil caused a significant reduction in PRSW for both low and high doses, and for dP/ dt max only at the high dose. Nicorandil tended to decrease the contractility index.
Effects of Test Compounds on Left Ventricular Lusitrope
Regardless of the dose, chromanol 293B altered neither tau nor dP/dt min (Fig. 6) . In contrast, metoprolol increased tau and dP/dt min in a dose-dependent manner. Metoprolol also significantly increased isovolumetric relaxation time (RT) at both low and high doses equally when compared with vehicle. Neither milrinone nor nicorandil changed tau, but both increased (ie, made more positive) dP/dt min significantly for the high doses. Chromanol 293B and nicorandil did not alter the ratio of EDV and EDP whereas milrinone increased the EDV/EDP at the high dose and metoprolol decreased the ratio at the high dose significantly (p < .05).
FIg. 3.
Effects of selected compounds (chromanol 293B, n = 8; milrinone, n = 6; metoprolol, n = 7, and nicorandil, n = 8) on (A) RR interval, (B) PQ interval, (C) QT interval, and (D) QTcF interval in anesthetized guinea pigs after intravenous administration of different concentrations. A bolus of metoprolol was given at the end of each preparation to validate the negative inotropic responses. Each point represents the mean ± standard error of mean (SEM). *p < .05, **p < .01, and ***p < .001 versus percentage change of vehicle from baseline-adjusted value.
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Relationships of Contractility Index, dP/dt max , and QA Interval to PRSW
The contractility index (CI) related linearly and significantly (r 2 = .952, p < .001) to PRSW (Fig. 7A) ; dP/dt max related linearly (p = .029) but with an r 2 of only .251 to PRSW (Fig. 7B ). The QA related linearly (p = 0.002) but with an r 2 of only .456 (Fig. 7C) .
dISCuSSIOn
This study was intended to determine how reliably indirect indices of contractility (contractility index, dP/dt max , QA interval) relate to a load-independent well-established "gold standard" inotropic index, the PRSW, when ventriculo-vascular mechanics, duration of electrical systole (QT interval), and heart rate were altered by pharmacological agents. In this study, electrocardiograms, left ventricular pressure-volume loops inscribed during heterometric autoregulation, as well as systemic arterial pressure recordings, satisfactory for addressing this issue were obtained in healthy guinea pigs anesthetized with sodium pentobarbital, exposed to escalating concentrations of well-established drugs affecting ventriculo-vascular mechanics, heart rate, and conductance over specific ion channels. The drugs used in this study were: chromanol 293B (lengthens QT interval), metoprolol (negative inotrope and slows heart rate), milrinone (positive inotrope and vasodilator), and nicorandil (shortens QT interval).
Guinea pigs were studied because they have been used as surrogates for humans to evaluate effects of pharmacological agents on electrophysiological and mechanical parameters that if affected by test articles may translate to morbidity and/ or mortality (Hamlin, 2007; Hamlin et al., 2003; Hauser et al., 2005) . Although sodium pentobarbital affects physiological parameters and possibly interactions between those parameters and pharmacological agents, pentobarbital was used because it produces a preparation in which heart rate and rhythm, ventricular mechanics, and system arterial pressure are stable (Mooney et al., 2012) . Ventilation with 95% oxygen and 5% carbon dioxide was used to sustain normal hemoglobin oxygen saturation and pH in systemic arterial blood. All guinea pigs survived the entire protocol, records of quality satisfactory for analysis were obtained, and all guinea pigs maintained sinus rhythms.
The guinea pig is already used often in preclinical studies in safety pharmacology and toxicology. It is convenient since it is relatively inexpensive to purchase and house when compared with dog, it requires relatively small amounts of oftentimes expensive test articles, its electrocardiogram possesses "human-like" P, QRS, and ST-T components, and it possesses ion channels like humans except for absence of transient outward potassium channel, I TO (Cieślar et al., 1986; McDermott et al., 2002; Kijtawornrat et al., 2011) . The guinea pig differs from other mammals because-among other comparisons-it has relatively low systemic arterial pressure generating often curvilinear ESPVRs, it lacks single, large femoral arteries for catheterization, and it has the most complete coronary collateralization of any mammal. Nevertheless, changes in mean blood pressure were detected with reference compounds as anticipated (Fig. 4) .
In dogs, large databases are well established and available. Dogs are easy to handle and less susceptible to stress. However, this species are known to oversensitive to vasodilating agents which may result in myocardial necrosis (Dogterom et al., 1992) . Thus drugs that possess vasodilation may give false positive result in dog study and consequent human translatability.
Electrophysiological effects of each drug occurred in a dosedependent manner and were consistent with their known pharmacological properties. For example, metoprolol, a β 1 -adrenergic blocking agent, lengthened the RR interval (ie, slowed heart rate), and prolonged QT and QTcF equally (Dorostkar et al., 1999; Yoshiga et al., 2002) . That the correction for heart rate did not extinguish the lengthening of QT interval is due, no doubt, to the limitation of the Fridericia equation for adjusting QT interval for heart rate (Chiladakis et al., 2010; Hamlin et al., 2003) . Chromanol 293B, a known blocker of I Ks , did not alter RR interval but lengthened both QT and QTc intervals (Cheng and Incardona, 2009 ). Nicorandil, known to accelerate exit of potassium through I KATP , shortened both QT and QTc intervals (Yang et al., 2004) . Milrinone, increased PRSW [due to both increased inotrope and to increased heart rate (chronotropic-inotrope)], decreased systemic arterial pressure (due to vasodilatation), and increased heart rate (due to activation of the baroreceptor reflex) (Royse et al., 2007) . All of these results
FIg. 4.
Effects of selected compounds (chromanol 293B, n = 8; milrinone, n = 6; metoprolol, n = 7, and nicorandil, n = 8) on mean systemic arterial blood pressure (MBP) in anesthetized guinea pigs after intravenous administration of different concentrations. A bolus of metoprolol was given at the end of each preparation to validate the negative inotropic responses. Each point represents the mean ± standard error of mean (SEM). *p < .05 versus percentage change of vehicle from baseline-adjusted value.
suggested that the electrophysiological and contractility profiles of four test compounds with known action were correctly evaluated in the current guinea pig model demonstrating the utility of this model for preclinical safety assessment.
Whereas it is thought that lengthening of QTc by 20%-40% or by 50%-60% indicates moderate or severe risk for developing torsades de pointes in man, there are no values to changes in any other parameter of cardiovascular physiology that are known to translate to moderate or to severe risk. Of course a precipitous change, in man, of any parameter may be considered an adverse event; the risk is modulated by comorbidities and by pleomorphisms in receptors affecting responses to drugs.
Mean systemic arterial pressure was not affected by chromanol 293B, but decreased significantly and in a dose-response manner to metoprolol (due to reduction in heart rate and negative inotrope), to milrinone (due to vasodilatation dominating positive inotrope), and to nicorandil (due to vasodilatation).
Myocardial contractility was assessed by the slope of the PRSW, and not derived from the ESPVR (the end-systolic elastance, Ees). The Ees is a function of systemic arterial pressure (~100 mmHg in all mammals) and ventricular volume (varying enormously according to body mass). Therefore the ratio, aortic pressure/volume, varies dramatically according to the mass of the animal. Furthermore the ESPVR is known to be curvilinear in small animals (Sato et al., 1998) and at lower systemic arterial pressures (Burkhoff et al., 1987) ; guinea pigs are known to have the lowest systemic arterial pressure of any mammal. Thus the slope of a line-most often a curve at lower pressures-connecting many ESPV points obtained during heterometric autoregulation varies greatly according to mass, and is often too curvilinear to be represented by a single straight FIg. 5. Effects of selected compounds (chromanol 293B, n = 8; milrinone, n = 6; metoprolol, n = 7, and nicorandil, n = 8) on (A) preload recruitable stroke work (PRSW), (B) the maximum rate of the rise of left ventricular pressure (dP/dt max ), (C) contractility index, and (D) QA interval in anesthetized guinea pigs after intravenous administration of different concentrations. A bolus of metoprolol was given at the end of each preparation to validate the negative inotropic responses. Each point represents the mean ± standard error of mean (SEM). *p < .05 and ***p < .001 versus percentage change of vehicle from baseline-adjusted value.
line (Kass et al., 1989) . On the other hand, PRSW is relatively constant (60-100) among conscious mammals since it is a function of systemic arterial pressure (~100 mmHg) times the ratio of stroke volume to end-diastolic volume (~0.6), the ratio being relatively constant among mammals (Feneley et al., 1992; Glower et al., 1985) .
Lusitrope (ease of ventricular filling) was assessed by dP/ dt min , tau, and duration of isovolumetric relaxation-all occurring during isovolumetric relaxation before the ventricle actually filled-and by the ratio of end-diastolic volume to enddiastolic pressure, a static point after the ventricle had filled completely (Garcia et al., 2000) .
Tau changed (ie, lengthened) only in response to metoprolol. Since tau is also affected by heart rate, the lengthening observed would be expected based upon cardiodeceleration alone; however, β 1 -blockade would also be expected to manifest negative lusitrope since the rate of resequestration of Ca ++ from troponin-C to the sarcoplasmic reticulum through the SERCa ++ channel is hindered by phospholambam; phospholamban being inactivated (therefore Ca ++ is resequestered more rapidly) by phosphorylation produced by β 1 efferent traffic. Thus if a β 1 -blocker prevents phosphorylation, less Ca ++ is driven through the SERCa ++ channel, and relaxation is slowed, producing negative lusitrope (Bristow, 2011) . No other drugs affected tau. dP/dt min is affected by lusitrope (determined by rate of resequestration of Ca ++ from troponin-C to the sarcoplasmic reticulum, by structural properties of the myocardium, by constriction of the pericardium or pericardial effusion, by reduction in heart rate, and by diastolic systemic arterial pressure (McConnell et al., 2009) . dP/dt min was unchanged by chromanol 293B, but became more positive (ie, less negative) in a dose-response manner to metoprolol, milrinone, and nicroandil. This negative FIg. 6. Effects of selected compounds (chromanol 293B, n = 8; milrinone, n = 6; metoprolol, n = 7, and nicorandil, n = 8) on (A) time-constant of the left ventricular relaxation (tau), (B) the maximum rate of the fall of the left ventricular pressure (dP/dt min ), (C) isovolumetric relaxation time, and (D) the ratio of end-diastolic volume/end-diastolic pressure in anesthetized guinea pigs after intravenous administration of different concentrations. A bolus of metoprolol was given at the end of each preparation to validate the negative inotropic responses. Each point represents the mean ± standard error of mean (SEM). *p < .05 versus percentage change of vehicle from baseline-adjusted value. lusitrope could be caused by a reduction in heart rate produced by metroprolol, or by a decrease in diastolic systemic arterial pressure produced by milrinone.
It is interesting and important for interrogation of lusitrope that both tau and dP/dt min demonstrated negative lusitrope produced by metoprolol, however only increasing of dP/dt minbut not lengthening of tau-indicated negative lusiotrope for milrinone and nicorandil. Negative lusitrope was indicated by increased duration of isovolumetric relaxation (relaxation time) only for metroprolol. Relaxation time tended to decrease for both nicorandil and milrinone. Thus all indices of lusitrope were concordant for metoprolol while tau and relaxation time were concordant for milrinone and nicorandil. This discordance may be due to the load-dependence and heart rate dependence of these indices, and the fact that each test article affected the determinants differently.
The ratio, EDV:EDP, often referred as "static compliance," is a heart rate-independent index of lusitrope, therefore it can be considered best for characterization of that property (Pearson et al., 1987) . Therefore metoprolol was, in fact, a negative lusitrope, and milrinone was, in fact, positive lusitrope. Thus EDV:EDP might be the correct indicator of lusitrope, whereas tau, dP/dt min , and relaxation time were considered less valid measures of lusitrope.
PRSW, dP/dt max , contractility index [(dP/dt/P) max ] and QA interval are all used as indicators of inotrope. PRSW is the "gold standard." In this study, considering all test articles, correlation between PRSW and contractility index occurred with a r 2 of .952, p < .001. Thus both might be used as monitors of inotrope for all test article interrogated. However, r 2 s for PRSW (for all test articles) with either dP/dt max (r 2 = .251, p = .029) or QA (r 2 = .456, p = .002) indicate that only 25%, for dP/dt max and 46%, for QA interval were attributable to contractility (ie, PRSW) and thus would be limited to predict contractility. For predicting inotrope by dP/dt max , compared to PRSW, r 2 s were .064 for milrinone and .119 for metoprolol, whereas for nicorandil r 2 was .44. Thus dP/dt max is moderately to severely limited for monitoring inotrope of three of the test articles.
As shown in the results, changes in all physiological parameters obtained from PVLs in all guinea pigs concur with known effects in other animals. For example, for all guinea pigs, heart rate slowed and slope of PRSW became less steep in response to metoprolol, a β 1 -adrenergic blocker; slope of PRSW increased and systemic arterial pressure decreased in response to milrinone, an inodilator; QTc lengthened in response to chromanol-293B and shortened in response to nicorandil, an opener of IK ATP . Thus all guinea pigs responded, qualitatively, to test articles in concurrence with the known pharmacology of the test articles. We do not know if the responses were concurrent, quantitatively, because the magnitudes of responses depend upon too many factors (eg, species, strains, sex, and age of animals, anesthetic regimen and depth of anesthesia).
As far as we are aware, three of four reference compounds were used in humans. In patients with dilated cardiomyopathy and severe heart failure, milrinone significantly increased contractility index and heart rate whereas it reduced mean blood pressure and vascular resistance (Bregagnollo et al., 1999) . In patients with coronary artery disease, nicorandil administration resulted in a reduction of mean arterial pressure and contractility. The transiently increased heart rate was also observed (Coltart and Signy, 1989) . In patients undergoing cardiac catheterization, intravenous administration of metoprolol produced a remarkable reduction of heart rate, dP/dt max , and mean blood pressure (Bourdillon et al., 1979) . Based on available data studied in humans and guinea pigs, the results of those compounds in the present study were well correlated with the results in humans. Therefore, the anesthetized guinea pig model instrumented for measurement of cardiac function simultaneously with electrocardiographic properties is considered a suitable model to use in preclinical safety assessment of new chemical entities.
The present study can demonstrate that (1) contractility index is a favorable predictor of contractility, while dP/dt max , and QA interval are unacceptable, (2) lusitrope is best monitored as EDV:EDP, and (3) both electrophysiological and mechanical parameters may be monitored simultaneously and accurately in anesthetized guinea pigs. 
